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Abstract: Maternal hyperglycemia alters an offspring’s metabolic health outcomes, as demonstrated
by the increased risk for obesity, impaired glucose handling and diabetes from early childhood
onwards. Infant growth patterns are associated with childhood adiposity and metabolic health
outcomes and, as such, can be used as potential markers to detect suboptimal metabolic development
at an early age. Hence, we aimed to assess whether gestational diabetes mellitus (GDM) has an
impact on offspring growth trajectories. Outcomes included weight gain (WG), body mass index
(BMI), and skin fold thickness (SFT) measured at least at two time points from birth to later childhood.
In addition, we explored the role of early life pre- and post-natal nutritional modifiable factors on
longitudinal growth in infants of mother with GDM (GDM–F1). Despite the large heterogeneity of
the studies, we can still conclude that GDM seems to be associated with altered growth outcomes in
the offspring. More specifically, these alterations in growth outcomes seem to be rather time-specific.
Increased SFT were reported particularly at birth, with limited information on reporting SFT between
2–5 y, and increased adiposity, measured via SFT and BMI, appeared mainly in later childhood
(5–10 y). Studies evaluating longitudinal growth outcomes suggested a potential role of early life
nutritional modifiable factors including maternal nutrition and breastfeeding. These may impact
the cycle of adverse metabolic health by attenuating growth outcome alterations among GDM–F1.
Conclusions: Timely diagnoses of growth deviations in infancy are crucial for early identification of
GDM–F1 who are at risk for childhood overweight and metabolic disease development.
Keywords: gestational diabetes; offspring; longitudinal growth; adiposity; skin fold thickness; body
mass index; weight gain; diet; maternal nutrition; breastfeeding
1. Introduction
From conception to birth, specific changes in maternal metabolism ensure an adequate supply of
nutrients to the fetus. Insulin resistance increases gradually under the influence of placental hormones,
increasing the requirements for maternal insulin to maintain adequate glycemic control during
pregnancy [1,2]. Glucose metabolism adapts adequately to the changing needs during pregnancy.
However, in the case of insufficient pancreatic capacity, gestational diabetes mellitus (GDM) may
develop [3]. GDM currently affects 1 out of 7 births worldwide [1]. Risk factors predisposing to GDM
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include excessive pre-pregnancy adiposity, advanced maternal age, a family history of type 2 diabetes
mellitus (T2DM), a history of GDM, not exposed to breastfeeding in a previous pregnancy, a previous
large or macrosomic baby, short maternal stature, polycystic ovary disease, previous stillbirth, high
blood pressure during pregnancy, multiparity, as well as an unhealthy diet and sedentary lifestyle [4,5].
The median prevalence of GDM ranges from 12.9% in the Middle East followed by around 11% in
Southeast Asia, Western Pacific, and South and Central America to 5.8% in regions in Europe [6].
It must be noted that aside from the different ethnic backgrounds, the substantial variation in the
prevalence of GDM in each country is also influenced by the different screening and diagnostic criteria
used [6].
Although GDM most often resolves post-partum, it can have immediate and long-term adverse
health outcomes for both mother and offspring. Women with GDM are at risk of developing
hypertension disorders during pregnancy (including pre-eclampsia) and are more prone to develop
T2DM (50% affected within 10 y of a GDM pregnancy) [1,7]. The excess supply of nutrients can
lead to fetal hyperinsulinemia and increased fetal growth, resulting in a higher prevalence of
macrosomia, shoulder dystocia, respiratory distress, hypoglycemia, polycythemia, hyperbilirubinemia,
and caesarean delivery of the new-born infant [8]. Moreover, hyperglycemia in the intrauterine
environment has an impact on the offspring’s metabolism, as evidenced by their increased risk for
obesity, impaired glucose handling, metabolic syndrome, and T2DM in later life [9]. Thus, GDM is a
condition that fuels a viscious circle of predisposition to metabolic disorders across generations.
Fetal and infant growth trajectories play a pivotal role in the development of childhood obesity
and associated metabolic outcomes. A deeper understanding of the impact of GDM on offspring
growth and body composition development is essential to identify critical windows for metabolic
development and/or the development of suitable intervention strategies. Moreover, understanding
the impact of early life modifiable factors on adiposity alterations in GDM offspring is of importance;
especially important is evaluating the impact of perinatal maternal diet (pregnancy and breastfeeding)
and infant feeding pattern on offspring obesity risk throughout life [10].
Longitudinal growth outcomes of offspring born from women with GDM (GDM–F1) are poorly
described, particularly in relation to their use as potential early markers of metabolic disorders.
Most of the available studies either focus solely on birth outcomes or provide a cross-sectional
analysis of childhood growth outcomes and lack a clear longitudinal and follow up overview of
ages at which growth alterations may become evident. Formulation of preventive strategies for the
development of childhood obesity in this particular population require evaluation of longitudinal
growth measurements [11]. Thus, the aim of this narrative review was to determine whether GDM–F1
offspring show time-specific alterations in growth outcomes such as weight gain (WG), body mass index
(BMI), and adiposity (as measured by skin fold thickness (SFT)) during infancy, and childhood. As such,
we primarily reviewed studies in which one of those parameters was measured at a minimum of two
different time points. In addition, we also focused on the relationship between maternal nutrition
and feeding patterns (as two nutritional modifiable factors) and longitudinal growth outcomes
among GDM–F1.
2. Review of the Evidence
We observed a large heterogeneity in the reviewed studies reporting longitudinal growth data in
GDM offspring. Apart from differences in reported growth outcome parameters, e.g., using standard
deviation (SD) scores, percentiles or absolute values, a large variety of assessment ages and number of
data collection timepoints were apparent across studies. Moreover, different reference groups were
used, such as women with normal glucose tolerance (NGT–F1) [12–23]; women with pre-gestational
diabetic (Type 1 and Type 2) [16,24,25], women with milder levels of glucose intolerance [21,26], World
Health Organization (WHO) standards or country specific reference data [27]. Despite this large
heterogeneity, we aimed to summarize the data in a narrative review that aims to provide insight
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into alterations in growth outcomes of GDM–F1 as potential early predictive markers for childhood
overweight risk. We provide details of our search strategy in the Supplementary Methods.
2.1. Longitudinal Growth Outcomes in Offspring Born to GDM vs. Control Group
Differences in WG, BMI and SFT between GDM–F1 and different control groups were reported
over a wide age range (Table 1), e.g., from 0–5 y; 5–10 y and ≥ 10 y. More information is provided in
Supplementary Tables S1 and S2.
2.2. Pattern of Weight Gain among GDM–F1
Weight gain in early infancy is more rapid than any other post-natal period of life and rapid
weight gain in infancy is a well-established marker of possible alterations in metabolic health in later
life [28].
Interestingly, during the first year of life, both increased [29,30] and decreased [14] WG for
GDM–F1 compared to controls was reported. In one study, the presence of GDM resulted in slower
WG (based on weight for length) of GDM–F1 compared to non-GDM peers. The authors suggested that
excess cord blood leptin and hormone levels of the intrauterine environment may have altered blood
insulin levels, decreased appetite and increased metabolism during early infancy and, as such, may
have contributed to the observed lower WG [14]. The study reporting a higher WG in GDM–F1 was
conducted in infants born from women with both obesity and GDM versus lean women with NGT [30].
The co-existence of maternal hyperglycemia and high maternal BMI could potentially explain the
observed increased WG among their offspring.
Given the impact of tempo of infant weight gain in the first few months of life on later life health
outcomes [28], the observed alterations in the WG of GDM–F1 emphasize the importance of careful
monitoring of GDM–F1 during early life.
2.3. Body Mass Index Trajectory in GDM–F1
BMI was the most commonly reported growth characteristic among offspring of GDM mothers.
Sequential measurements of BMI enable the identification of the timing of adiposity rebound, the
period when weight gain velocity increases due to a rise in the number and size of adipocytes; it
has been suggested that early adiposity rebound is a marker for later obesity risk [31]. To envisage
childhood obesity and to construct preventive strategies among GDM–F1, understanding longitudinal
assessment of BMI, timing of adiposity rebound, and the subsequent risk of overweight/obesity (ow/ob)
development are of importance [11].
Based on the reviewed studies which measured BMI (for at least two time points during the study),
from birth till 5 y, no differences in BMI were observed between GDM–F1 and NGT–F1 [12,19,26,32,33].
There was one exception, a study which reported higher BMI at approximately 1 y in large for
gestational age infants born to women with GDM (GDM-LGAF1) versus large for gestational age
infants born to women with normal glycaemia (NGT–LGAF1) [17].
Studies with a longer time follow up indicated higher BMI values in infants of GDM women at a
later age of 5 y [22], 7 y [12,18], around 10 y [34], 5–10 y [26], versus control groups, although others
did not [19,35].
One study investigated and reported an earlier timing of adiposity rebound in GDM–F1 compared
to NGT–F1 (4.4 y vs. 5.5 y) [24].
A few longitudinal studies examined BMI trajectories of two sub-groups of GDM–LGAF1 and
GDM–nonLGAF1 beyond 1 y of age. Two studies suggested a higher BMI at 7 y [18], and BMI SDS
at 8–14 y [11] for GDM–LGAF1 compared to GDM–nonLGAF1. The observed higher BMI trajectory
of GDM–LGAF1 is in line with findings from cross sectional studies that GDM–LGAF1 at birth
had increased fat mass and decreased lean mass compared to NGT–LGAF1 and suggests that their
disproportionate body composition at birth could track in later life [36].
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Table 1. Effect of exposure to gestational diabetes mellitus (GDM) on growth characteristics of offspring (compared to various control groups).
Category Subcategory Weight Gain (Exact Time Point) Skinfold Thickness (Exact Time Point) Body Mass Index (Exact Time Point)
0–5 y 0 (Birth) Increased (birth) [17] b [22,33,37] c No difference (birth) [17,19] b [32,33] **×
0–6 m
Decreased (0–6 m) [14] *
Increased (0–6 m) [30] a
Increased (11 d to 8–12 w) [29]
No difference (11 day) [29]
Increased (6 w) [30] a×
Increased (8–12 w) [29]
No difference (4 m) [30] a×
No difference (1–6 m) [19] ×
0–1 y No difference (0–1 y) [20,21] d No difference (6 m–1 y) [19]
1 y No difference (1 y) [30] a [17,21,22] c× No difference (1 y) [33] **
× [22] ×
Increased (1 y) [17] b
2 y Increased (2 y) [22] only girl × No difference (2 y) [33] **×
3 y No difference (3 y) [33] ** [26] d [12]
4 y No difference (4 y) [26] d [12] ×
2–5 y No difference (2–5 y) [19] ×
5–10 y 5 y Increased (5 y) [22] c× Increased (5 y) [22] only girl ×
≥ 7 y Increased (7 y) [18]
b× [37] (only girl) Increased (7 y) [18] b× [12] **×
Increased (7.1 –8.7 y) [35] fj No difference (7.1–8.7 y) [35] **j×
5–10 y Increased (9. 5 y) [34] c (only girl)
Increased (9.5 y) [34] (only girl)
Increased (5–9 y) [26] d×
No difference (5–10 y) [19] **
≥ 10 y Increased (median 11 y) [38] Increased (10–14 y) [11]
b×
No difference (14–17 y) [16] e×
* WFL Z = weight for length Z score; ** BMI Z = body mass index Z score; × Longitudinal studies measured trajectory of body mass index or skin fold thickness at more than two time
points; a. Ob–GDM–F1 vs. (Lean–NGT–F1 or Ob–NGT–F1) = offspring born to mother with high pre–pregnancy BMI and gestational diabetes vs. mother with normal BMI and normal
blood glucose tolerance or mother with high pre-pregnancy BMI and normal blood glucose; b. GDM–LGAF1 vs. NGT–LGAF1 = large for gestational age offspring born to mothers with
gestational diabetes vs. mothers with normal glucose tolerance; c. Subscapular and tricepses; d. GDM–F1 vs. IGT–F1= offspring born to mothers with gestational diabetes vs. mothers with
intolerance glucose test; e. GDM–F1 vs. T1DM + T2DM = offspring born to mothers with gestational diabetes vs. mothers with type one or two diabetes; f. Subscapular and triceps; j.
GDM– vs. IGT vs. IH vs. NGT = offspring born to mothers with gestational diabetes vs. intolerance glucose test vs. isolated vs. normal glucose tolerance.
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In line with the higher BMI values, 5 out of 10 studies focusing on the first 7 y of life showed 4–12%
higher percentages of ow/ob in GDM–F1 compared to NGT–F1 or DM–F1 [12,13,19,24,37]. Likewise,
in children with median age of 11 y, the HAPO study indicated that GDM–F1 had higher percentage of
overweight or obesity compared to the NGT–F1 (29% vs. 39%) [38]. However, it must be noted that the
use of different BMI cut offs and criteria, including International Obesity Task Force (ITOF), Centers for
Disease Control (CDC), and country specific cut-offs make it difficult to compare the prevalence of
overweight and obesity across studies.
Based on the available evidence it seems that, in addition to the effect of maternal GDM on
short-term infant growth outcomes such as being born LGA or having a higher weight gain during
infancy, maternal GDM may also have long-term adverse effects on BMI development trajectories
during later life. Hence, it is crucial for parents and health care workers to consider this risk even
when not being born big in GDM–F1 and, as such, to monitor BMI longitudinal patterns till late
childhood/early adolescence [11].
2.4. Skin Fold Thickness Trajectory among GDM–F1
Assessing fat deposition in addition to BMI could clarify whether adiposity could be a plausible
underlying mechanism related to increased metabolic risks reported for GDM–F1. Consistently higher
SFTs were reported at birth in GDM–F1 versus NGT–F1 [17,33,34,37] (Table 1). These differences
remained for the first months of life, although only investigated in a few studies [29,30], At 1 y of
age the differences observed at birth and early life were no longer apparent [17,21,22,30], and limited
information was available on SFT between 2–5 y of age.
Interestingly, at an older age (5–10 y), in line with the increased BMI values reported, the higher
SFT in the GDM–F1 seen at birth re-appeared; it was consistently evident at 5 y [22], 7 y [18,37], around
8 y [35], and around 10 y [34]. Likewise, the HAPO follow up study confirmed higher SFT of GDM–F1
around 11 y old compared to NGT–F1 [38].
Taken together these findings reinforce the concept of Pedersen’s hypothesis, which postulates that
increased maternal hyperglycemia, resulting in fetal hyperinsulinemia, may stimulate adipose tissue
growth in infants [39]. The age-dependent disappearance and re-emergence of the association between
maternal GDM and markers of adiposity in offspring suggests that GDM could have a differential
impact on lean and fat mass development [40].
Interestingly, two studies evaluated fat mass distribution using either ultra-sonographic
imaging [30] or body magnetic resonance imaging [29] in infants. Both studies indicated that visceral
adiposity in GDM–F1 was amplified in infancy at a median age of 10 w [29] and at approximately
1 y [30]. Given the known tracking of adipose tissue depots throughout infancy and childhood,
and their role in later childhood obesity [41,42], this illustrates the potential impact of the observed
different pattern of fat mass distribution on later metabolic health among GDM–F1. In conclusion,
there is a clear need for more longitudinal examinations of anthropometric and adiposity development,
preferably with more frequent assessments in the first year of life and yearly assessments thereafter up
to late childhood, as well as distribution of adiposity in GDM–F1 both in early infancy and childhood,
in order to truly map and understand the potential long-term health implications.
2.5. The Relationship between Early Life Nutritional Modifiable Factors and Trajectory of Growth among
GDM–F1
Offspring of GDM may provide us with a unique population to study and gain more insights
into the origins of obesity. It is likely that alterations of adiposity among GDM–F1 are influenced
by several pre- and post-natal factors. In this review, we specifically focused on the influence of the
pre- and post-natal maternal diet as well as offspring milk feeding patterns on growth outcomes in
GDM–F1. However, other pre-natal modifiable factors including maternal pre-pregnancy BMI and
gestational weight gain may affect the association between maternal glucose tolerance and changes in
growth outcome [9,11,14,22,34]. The impact of these pre-natal factors might even have an interaction
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with GDM; the combination of maternal GDM and obesity has a greater impact on offspring growth
outcomes than the single factors alone [38]. Therefore, their independent effects as covariant have been
examined in several of the included studies.
2.6. Pre- and Post-Natal Maternal Diet
Dietary control is normally the first line of treatment for women with GDM. It should be culturally
appropriate, individualized and promote adequate and healthy nutrition for mothers and fetus [43].
Hence, nutritional advice tailored to an individual’s situation and phenotype will become a key asset
to control maternal blood glucose [5].
Most of the modified dietary recommendations for women with GDM are from studies which only
investigated the association of maternal diet and offspring growth and body composition at one time
point—either at birth [44,45] or later in childhood [46]. For example, the recent systematic review by
Yamamoto et al. concluded that dietary interventions for women diagnosed with GDM in RCT studies
favorably affected birth outcomes, with lower birth weights (170 g), and less relative risk of macrosomia
(0.49) [47]. Whereas, the DANISH birth cohort longitudinally assessed the intergenerational effect
of maternal nutrition of women on repeated parameters of growth during infancy up to early or
later childhood. The result showed that a high intake of refined grains (>4.3 servings/day vs. <1.8
servings/day) increased the risk of obesity at 7 y among GDM–F1 but no association was observed
between high intake of grain and BMI z-score at 5 month and 1 y [48]. This study also showed that diets
with low quality foods, for example low level of fiber content, may alter satiety hormone profiles and
expression of genes involved in glucose and lipid metabolism and increase adiposity in the offspring.
Another subgroup analysis study from the Danish National Birth Cohort focused on the quality of
carbohydrates in relation to longitudinal infant growth outcomes among GDM–F1. They demonstrated
that consuming high glycemic index (GI) and glycemic load (GL) diets were related to a modest
increase in the relative risk of LGA after adjustment and potential increase in total fat mass percentage
(30% vs. 26%) and abdominal fat mass percentage (26.8% vs. 21.3%) among GDM–F1 vs. NGT–F1 at
around 9–16 y [49].
In addition to the quality of the maternal diet, the timing of nutritional disturbances and insults
during different trimesters may have specific physiological relevance on alterations in pancreatic
structure or secretory capacity in offspring. Adipose and pancreatic tissue structural development
starts already in first trimester, but fetal insulin secretion normally only starts during the second half
of the pregnancy [49]. In order to assess the longitudinal and intergenerational impact of perinatal
nutritional intervention among women with GDM on growth outcomes, it is crucial to focus on quality
and quantity of diet, particularly carbohydrates, and timing of the nutritional intervention. In addition,
early detection of hyperglycemic risk may be essential to prevent fetal growth deviations that result in
LGA or macrosomic births.
2.7. Feeding Patterns (Including Breast Feeding (BF))
Breastmilk is the best and sole source of nutrition for infants in the first six months of life [50].
A recent review by Rzehak et al. showed that, in a general pediatric population, a shorter duration
of BF (<3 m compared to ≥3 m) was associated with more rapid growth in early childhood and a higher
risk of obesity in later in life [51]. The effect of breast feeding (BF) of women with GDM on WG and
trajectory of BMI in GDM–F1 was assessed in only a couple of longitudinal studies [27,32,52]. In these
studies, the impact of partial breastfeeding as well as full breastfeeding was evaluated, however the
role of complementary feeding was not evaluated. However, it has been suggested that the influence
of timely complementary feeding needs to be further investigated [53]. Adequate (full or partial)
BF (>6 m) versus low (<6 m) decreased BMI among GDM–F1 with multi-ethnic backgrounds [52].
In addition, full or partial breastfeeding up to 5 m reduced BMI Z-score from 0–5 w (0.7 kg/m2) and
5 w–5 m (0.9 kg/m2) in the offspring of Danish women with GDM [27]. In contrast, full or partial
breastfeeding (>4 m BF versus no BF) accelerated conditional WG (0.72 g) and BMI Z-score (0.49 kg/m2)
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only from 0–6 m in offspring of Asian women with GDM [32]. Hence, while any duration of BF has
a positive effect on reduction of the risk of obesity in NGT–F1, based on these few studies, only a
prolonged duration of BF seems to mitigate the risk imposed in utero for higher WG and BMI among
GDM–F1 [53].
3. Conclusions
Longitudinal growth characteristics in GDM–F1 during early postnatal life and childhood are
scarcely studied and the retrieved studies showed a large heterogenicity in design. However, our review
still highlights the growing, but limited, number of reports showing deviations in BMI and SFT in of
GDM–F1 compared to NGT–F1 and other defined control groups. GDM appears to have a time-specific
effect on the quality of growth in the offspring marked by an indication for increased weight (gain) and
adiposity (SFT) particularly at birth and increased adiposity (SFT and BMI) in later childhood (5–10 y).
Interestingly, a limited evidence base suggests that the adverse health impact of exposure to maternal
GDM on offspring adiposity and growth outcomes may be attenuated by improving healthy maternal
diet and prolonged duration of BF.
Supplementary Materials: The following are available online at http://www.mdpi.com/1660-4601/17/9/3187/s1.
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